Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 7890 for “"T Cell"”.
-
Secrets of T-cell crowds: How complexity emerges in T-cell repertoires and T-cell migration
Contains fulltext : 236680.pdf (Publisher’s version ) (Open Access)
-
Engineering T Cell Metabolism for Enhanced CAR T Cell Efficacy
Chimeric antigen receptor (CAR) T cell therapy represents a step-change improvement in outcomes for patients with treatment-resistant haematological malignancies. Despite this success, these results have not been replicated when CAR T cells are directed against solid tumours. The reasons for this …
-
The Characterization of T-Cell Manufacturing For Adoptive T-Cell Therapies
Adoptive T-cell therapy using genetically modified T cells has emerged as a potential therapeutic option for several malignancies. Central to the production of the cellular therapy is the manufacturing using a stimulation, genetic engineering, and expansion methodology. Within this framework, there …
-
Role of T cell receptor signaling in CD8 T cell memory
… for vaccination. The development of memory CD8 T cells is required for long-term protection against intracellular pathogens, such as viruses, and tumors. While the importance of memory generation has been recognized for over 30 years, the mechanism by which memory CD8 T cells arise during immune …
-
The role of T cell receptor affinity in CD4+ T cell differentiation
Naïve helper T cells become activated when their T cell receptor (TCR) recognizes a microbial peptide presented on MHCII (p:MHCII) by dendritic cells (DCs). During this interaction, DCs provide polarizing cues to guide T cell differentiation towards specific fates, like T follicular helper cells …
-
Multivalent immunomodulators for CAR T cell manufacturing and T cell-engager immunotherapy
… a treatment strategy in which immune cells are directed to eliminate cancer cells, represents an established therapeutic approach with a growing range of modalities and addressable disease indications. Two forms of cancer immunotherapy, chimeric antigen receptor (CAR) T cells and …
-
Regulation of T cell apoptosis and T cell activation through costimulatory signals
… and inhibition of activation-induced cell death (AICD). While signalling pathways activated through the costimulatory molecule CD28 are well defined, less is known about the molecular events induced by alternative costimulators. 4-1BB/CD137, a costimulatory member of the tumour …
-
INTERLEUKIN 2 INDUCIBLE T CELL KINASE (ITK) FINE TUNES T CELL DIFFERENTIATION
Regulation of T cell signal strength by interleukin 2 inducible T cell kinase (ITK) is a critical component in naïve CD4+ T helper (Th) and T regulatory (Treg) cell development. We hypothesized that absence of ITK activity will induce a switch in naïve T cell fate. Using ITK inhibitor CPI-818 …
-
Plasmodium suppresses T cell responses to heterologous infections by impairing T cell activation
… This study demonstrates that both dendritic cell and T cell activation are impaired following a Plasmodium infection, ultimately altering the adaptive T cell response to secondary infections. T cell suppression is evident early on following a secondary infection and continues throughout the …
-
Remote force application to the T cell receptor modulates CD4\(^+\) T cell activation
Whilst T cell receptor (TCR) signalling pathways become increasingly well understood, the precise mechanism by which TCR triggering is achieved remains elusive. Models of TCR triggering surrounding TCR aggregation or segregation from inhibitory phosphatases have provided compelling insight, but …
-
Homeostatic T Cell Receptor Interactions with Self-Peptide Tune CD4+ T Cell Function
Homeostatic T Cell Receptor Interactions with Self-Peptide Tune CD4+ T Cell FunctionbyJuliet Marie BartlesonDoctor of Philosophy in Biology and Biomedical SciencesImmunologyWashington University in St. Louis, 2021Professor Paul M. Allen, ChairMature CD4+ T cells circulate throughout peripheral …
-
Expression of Follicular Helper T-cell Markers in Primary Cutaneous T-cell Lymphoma
… and objectives: A distinct subset of T helper cells, named follicular helper T- (TFH) cells, have been recently described. The TFH-cells can be identified on the basis of the expression of several markers including: the chemokine CXCL13; the costimulatory molecules PD-1 and inducible …
-
Isolation of neoantigen-specific T cell receptors for T cell receptor gene therapy
In recent years, adoptive T cell therapy has brought a revolutionary change in the treatment for B-cell leukemias, lymphomas and multiple myeloma. Along with T cells modified with chimeric antigen receptors (CARs), there is ongoing development of T cells modified with T cell receptors (TCRs). TCR-T …
-
Contact allergen-specific T cell responses and the involved T cell receptor repertoires
Allergic contact dermatitis (ACD) is a T cell-mediated disease. Approximately 20% of the population in industrialised countries is affected by at least one contact allergy1. However, due to technical limitations, in vitro T cell activation has only been described for a few contact allergens so far. …
-
The Role of T Cell Receptor: Peptide MHC Affinity in T Cell Activation
… without the need for stabilization, using a T cell display system. T cells bearing the newly isolated TCR bound pepMHC and were activated in the absence of co-receptor. This result demonstrates the feasibility of engineering full-length TCRs on the surface of T cells using a retroviral vector.
-
Directing the immune response: T cells, T cell receptors and T cell receptor mimics
Embargo status: Restricted to TTU community only. To view, login with your eRaider (top right). Others may request the author grant access exception by clicking on the PDF link to the left.
-
Lyophilized Antibodies As Tools For Efficient T Cell Activation in CAR T Cell Therapy
T cells are a crucial part of the immune system; they maintain homeostasis and fight infections. CAR-T cell therapy is a type of cancer therapy that leverages T cells to fight cancer. This is done by taking T cells from the patient, engineering them to produce a chimeric antigen receptor (CAR), and …
Page 1 of 395